-+ 0.00%
-+ 0.00%
-+ 0.00%

ALAR <6785.TWO> SAYS CO SUBMITS APPLICATION TO US FDA FOR PHASE II CLINICAL TRIAL OF ALA-3000 FOR DEPRESSION TREATMENT

Reuters·10/16/2026 07:51:22

Please log in to view news